- Small-Molecule Compounds Boost CAR-T Cell Therapy in Hematological Malignancies
Xinping Cao et al, 2023, Current Treatment Options in Oncology CrossRef - Targeting Nuclear Export Proteins in Multiple Myeloma Therapy
Shambavi Richard et al, 2022, BioDrugs CrossRef - CAR-T Cell Therapy in Hematological Malignancies: Current Opportunities and Challenges
Xiaomin Zhang et al, 2022, Frontiers in Immunology CrossRef - Relapsed or refractory large B‐cell lymphoma after chimeric antigen receptor T‐cell therapy: Current challenges and therapeutic options
Raul Del Toro‐Mijares et al, 2023, British Journal of Haematology CrossRef - Disruption of the NKG2A:HLA-E Immune Checkpoint Axis to Enhance NK Cell Activation against Cancer
Jack Fisher et al, 2022, Vaccines CrossRef - XPO1 inhibition sensitises CLL cells to NK cell mediated cytotoxicity and overcomes HLA-E expression
Jack G. Fisher et al, 2023, Leukemia CrossRef - Selinexor Enhances NK Cell Activation Against Malignant B Cells via Downregulation of HLA-E
Jack G. Fisher et al, 2021, Frontiers in Oncology CrossRef - Impacting T-cell fitness in multiple myeloma: potential roles for selinexor and XPO1 inhibitors
Adam F. Binder et al, 2023, Frontiers in Immunology CrossRef - Exportin 1 governs the immunosuppressive functions of myeloid-derived suppressor cells in tumors through ERK1/2 nuclear export
Saeed Daneshmandi et al, 2024, Cellular & Molecular Immunology CrossRef - Treatment of multiple myeloma with selinexor: a review
Qianlei Huang et al, 2024, Therapeutic Advances in Hematology CrossRef - A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma
Di Wang et al, 2023, Journal of Translational Medicine CrossRef - A phase I study of selinexor combined with weekly carfilzomib and dexamethasone in relapsed/refractory multiple myeloma
Benjamin A Derman et al, 2023, European Journal of Haematology CrossRef - Therapeutic Targeting of Exportin-1 in Childhood Cancer
Basia Galinski et al, 2021, Cancers CrossRef